Navigation Links
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Date:8/19/2007

-T, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE or NEUVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the results of a clinical trial for PROVENGE, NEUVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercialization of PROVENGE, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at http://www.sec.gov.


'/>"/>
SOURCE Dendreon Corporation

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
Breaking Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
...is. - Marshfield Clinic has reached an agreem...tware developed by TeraMedica , a Milwaukee-based...n as Evercore, will be deployed to integrate all o...d non-medical images, then distribute them within ...ll make them available to Marshfield Clinic,s heal...
...Baird Venture Partners , the U.S. venture fund of ... on its presence in China by partnering with the I..., to serve portfolio companies as they establish a...nterview with WTN, Paul Carbone, managing partner ...ivate Equity Group, explained the venture fund,s p...
.... - Dr. Leroy Hood, a prominent molecular biologi...f directors of NimbleGen Systems , a Madison biot...sident of the Seattle-based Institute for Systems...cientific advisory board. , ,A former professor a...ia Institute of Technology , Hood gained notoriety...
Other Biology Technology:Visions: Carbone bullish on Wisconsin venture capital 2Visions: Carbone bullish on Wisconsin venture capital 3Visions: Carbone bullish on Wisconsin venture capital 4Visions: Carbone bullish on Wisconsin venture capital 5
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA Less acculturated Latino men have a more difficult time quitting smoking than those who are more acculturated to U.S. culture, but acculturation has no affect on Latinas odds of quitting
(Date:12/2/2009)PHILADELPHIA Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient,s future risk of death, according to published studies. Now, results of a ne
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Acculturation affects smoking cessation success among Latinos 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Introducing All New IEHP Superhero to Battle Childhood Obesity 54248 1Introducing All New IEHP Superhero to Battle Childhood Obesity 54248 2Introducing All New IEHP Superhero to Battle Childhood Obesity 54248 3PA Department of Health Confirms the First Human Case of West Nile Virus in Pennsylvania for 2009 54244 1PA Department of Health Confirms the First Human Case of West Nile Virus in Pennsylvania for 2009 54244 2PA Department of Health Confirms the First Human Case of West Nile Virus in Pennsylvania for 2009 54244 3Mediterranean Diet Plus Exercise Lowers Alzheimers Risk 54241 1Mediterranean Diet Plus Exercise Lowers Alzheimers Risk 54241 2Mediterranean Diet Plus Exercise Lowers Alzheimers Risk 54241 3
...large portion of plant seeds is endosperm. It has ...during the early stages of its development. In flo...lisation mechanism that arises among embryos and e...ds. The exact process, and the communication betwe... scientists. Researchers at the Max Planck Institu...
...e INVORAD project developed systems for real-time ...nsity Modulated Radiotherapy (IMRT). IMRT is a rad...outcomes by more accurately targeting tumours and ...lthy tissue. , The result is that patients only re... healthy tissue is preserved. , The problem with ...
...e Johns Hopkins scientists who first created "migh...ny Wyeth and the biotechnology firm MetaMorphix, a... mass in mice than a related potential treatment f...e new agent is a version of a cellular docking poi...ice, just two weekly injections of the new agent t...
Other Biology News:The secret love life of plants 2Sensors, a smart dose of medicine for cancer treatment 2Sensors, a smart dose of medicine for cancer treatment 3Mouse study: New muscle-building agent beats all previous ones 2
Benchtop Laminar Flow Hood (Environmental Control Module) from Terra Universal, Inc.
SlideHyb Glass Array Hybridization Buffer #1 from Ambion
Denhardt's powder mixture (for 50X stock solution) from AppliChem GmbH
...Mixes are optimised for SYBR Green I assays and co...titative PCR, with the exception of template and p...l levels of active SYBR Green I dye and Thermo-Sta...on buffer that enables detection of low copy numbe...
Biology Products: